Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Shares of Maryland-based, Colfax Corporation (CFX - Analyst Report) spiralled up to a new 52-week high of $57.66 a day after the manufacturing and engineering company announced it had signed an agreement to acquire CKD Kompresory a.s. from CKD Group.

CKD Kompresory, based in Prague, Czech Republic, is a leading supplier of multi-stage centrifugal compressors to the oil & gas, petrochemical, power and steel industries. The assets have been valued at $57 million, including assumption of debts. Colfax anticipates completion of the transaction in the fourth quarter 2013.
 
The assets once acquired will be integrated with Colfax’s Howden business and renamed as Howden CKD Compressors s.r.o. Addition of CKD Kompresory will enable further strengthening of Howden’s compressor business and open new gates for Colfax to penetrate deep into this end market as well as explore new growth opportunities. CKD Kompresory in 2012 generated roughly $40 million in revenue.

Colfax’s Howden was founded in 1854 and currently provides precision air and gas handling equipment for challenging applications. Its products are supplied to various industries including power generation, oil and gas, petrochemical, mining and steel.

Prior to this acquisition announcement, Colfax in Sep 2013 signed an agreement to acquire the Global Infrastructure and Industry (GII) business of Flakt Woods Group for €193 million, assuming debt. The completion is subject to closing conditions. Acquisition of GII will strengthen the company’s Howden business through its broad product portfolio and large customer base.

Colfax currently has a market capitalization of $5.9 billion and holds a Zacks Rank #3 (Hold). Other companies to look out for are Gorman-Rupp Co. (GRC - Snapshot Report), DXP Enterprises, Inc. (DXPE - Snapshot Report), and Dover Corporation (DOV - Analyst Report), each carrying a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ANI PHARMACE ANIP 25.07 +15.96%
BITAUTO HOLD BITA 35.21 +14.42%
E HOUSECHINA EJ 10.97 +9.05%
CANADIAN SOL CSIQ 26.96 +7.10%
KNIGHTSBRIDG VLCCF 12.50 +5.75%